Dr. Angel D. Tabuyo-Martin, MD

Dr. Tabuyo-Martin practices at Dignity Health Advanced Imaging - Sacramento, CA in Sacramento, California.

Dr. Tabuyo-Martin's NPI, 1003293523, was assigned on May 5, 2015. Dr. Tabuyo-Martin graduated from UC San Diego School of Medicine in 2015. Dr. Tabuyo-Martin holds California license A147327.

Dr. Tabuyo-Martin's primary practice is Dignity Health Advanced Imaging - Sacramento, CA, at 3301 C St Ste 500, Sacramento, CA 95816. The practice phone is (916) 434-7600.

Dr. Tabuyo-Martin's primary practice is Dignity Health Advanced Imaging - Sacramento, CA in Sacramento, California. Dr. Tabuyo-Martin is also affiliated with Dignity Health - Mercy General Hospital. The medical group on file is Mercy Medical Group. Dmand AI also links Dr. Tabuyo-Martin to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Tabuyo-Martin's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tabuyo-Martin practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Tabuyo-Martin's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Tabuyo-Martin's licenses on file in 2 states: California and Florida.

CMS data shows 505 Medicare services from Dr. Tabuyo-Martin across 15 procedure codes in 2024, for 177 Medicare patients. Medicare paid $38,612 for them.

CMS counts 177 Medicare patients who saw Dr. Tabuyo-Martin in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tabuyo-Martin's median patient age at 58, with 92% women.

In 2024, Dr. Tabuyo-Martin wrote 103 Medicare Part D claims for 50 patients. 92% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $358 in total drug cost. In 2021, CMS named 43 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Tabuyo-Martin for performance year 2024, reported through an alternative payment model (APM). Dr. Tabuyo-Martin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tabuyo-Martin as offering telehealth. CMS counts 12 procedures of removal of the uterus by Dr. Tabuyo-Martin, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Tabuyo-Martin, published from 2021 to 2023. Dr. Tabuyo-Martin's most frequent co-authors are Matthew Peter Schlumbrecht, MD, Mitchell Creinin, MD and Marilyn Huang, MD.

Dmand AI links Dr. Tabuyo-Martin to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 7 general payments to Dr. Tabuyo-Martin from 5 drug and device companies from 2018 to 2022. Education make up the largest share, 54% of the total. Medical Device Business Services, Inc. paid the most, $325.

Dr. Tabuyo-Martin graduated from UC San Diego School of Medicine in 2015.

Dr. Tabuyo-Martin is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.